News & Events
BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite
Stockholm May 23rd, 2023 BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite BioLamina announces […]
Meet us at ISSCR in Boston, June 14-17
Meet us at ISSCR in Boston, June 14-17 Join our team, Dr. Mats Falk, Dr. Noah Fereydouni and Dr. Karen […]
Meet us at ISCT in Paris, May 31 – June 3
Meet us at ISCT in Paris, May 31-June 3 Join our team, Veronica Byfield Sköld, Dr. Theresa Mader, Dr. Marina […]
-
past-eventsNovember 17-19, 2022
ISSCR Boston 2022-11
Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success
-
past-eventsOctober 25, 2022
LSCN 2022-10
London Stem Cell Network
-
OtherOctober 18-19, 2022
iPSC therapies 2022-10
-
OtherSeptember 28-29, 2022
BIOMEDevice 2022-09
-
OtherSeptember 27-30, 2022
Biotech week Cell Therapy 2022-09
Cell & Gene Therapy Manufacturing & Commercialization
-
OtherSeptember 21-23, 2022
ISSCR Madison 2022-09
Emerging Therapies at the Intersection of Genetic and Cellular Technologies
-
OtherSeptember 13-16, 2022
GSCN 2022-09
-
press-room13/06/2022
BioLamina AB sets the stage for US expansion by opening office in Boston
Stockholm June 13th, 2022 BioLamina AB sets the stage for US expansion by opening office in Boston B
-
press-room07/03/2022
BioLamina further Strengthens Leadership by appointing Pia van der Zee as Chief Commercial Officer
Stockholm March 7th, 2022 BioLamina further Strengthens Leadership by appointing Pia van der Zee as
-
OtherJune 15-18, 2022
ISSCR San Francisco 2022-06
The International Society for Stem Cell Research. Meet us at booth #513!
-
press-room18/10/2021
BioLamina with partners in the innovation milieu IndiCell receive SEK 40M to establish and propel individualized cell therapy treatments in Sweden
Stockholm October 19th, 2021 BioLamina with partners in the innovation milieu IndiCell receive
-
press-room30/09/2021
Appointment of new CEO at BioLamina AB
Stockholm September 30th, 2021 Appointment of new CEO at BioLamina AB The Board of Directors o
-
press-room14/09/2021
BioLamina AB expands production and office space to meet the fast-growing customer demand
Stockholm September 14th, 2021 BioLamina AB expands production and office space to meet the fa
-
press-room24/08/2021
BioLamina AB and Inventia Life Science partner to advance cell matrices for complex 3D cell models
Stockholm August 24th, 2021 BioLamina AB and Inventia Life Science partner to advance cell mat
-
press-room22/06/2021
BioLamina AB launches new website
June 22, 2021 BioLamina AB launches new website BioLamina (Stockholm) is thrilled to announce the la
-
press-room06/06/2021
BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of human diseases
June 9, 2021 BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system f